Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in Zucker diabetic fatty rats

Diabetes

Volumn 60, Issue 9, 2011, Pages 2225-2233

  Torres, Tracy P ^a   Fujimoto, Yuka ^a   Donahue, E P ^a   Printz, Richard L ^a   Houseknecht, Karen L ^b   Treadway, Judith L ^b   Shiota, Masakazu ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCONEOGENESIS; GLYCOGEN SYNTHESIS; HYPERGLYCEMIA; HYPERINSULINEMIA; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; BODY WEIGHT; GLUCONEOGENESIS; GLUCOSE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; LIVER; MALE; OBESITY; RATS; RATS, ZUCKER;

EID: 80052914660     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-1156     Document Type: Article

References (32)

1. Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 1992; 15:430-441
2. Ferrannini E, Groop LC. Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 1989;5:711-726 (Pubitemid 20097248)
3. Iozzo P, Hallsten K, Oikonen V, et al. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 2003;88:2055-2060 (Pubitemid 36549877)
4. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 1986;77:1525-1532 (Pubitemid 16053293)
5. Basu A, Basu R, Shah P, et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 2001;50:1351-1362 (Pubitemid 32500168)
6. Basu A, Basu R, Shah P, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 2000;49:272-283 (Pubitemid 30071006)
7. Krssak M, Brehm A, Bernroider E, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004;53:3048-3056 (Pubitemid 39564478)
8. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
9. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 1998;102:744-753 (Pubitemid 28399607)
10. Fujimoto Y, Donahue EP, Shiota M. Defect in glucokinase translocation in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 2004;287:E414-E423 (Pubitemid 39095874)
11. Fujimoto Y, Torres TP, Donahue EP, Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 2006;55:2479-2490 (Pubitemid 44871148)
12. Shin JS, Torres TP, Catlin RL, Donahue EP, Shiota M. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes. Am J Physiol Regul Integr Comp Physiol 2007;292:R1381-R1390 (Pubitemid 46557795)
13. Torres TP, Catlin RL, Chan R, et al. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 2009;58:78-86
14. Cline GW, Johnson K, Regittnig W, et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 2002;51:2903-2910
15. Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 1996;45:82-91 (Pubitemid 26104272)
16. Katz J, Dunn A, Chenoweth M, Golden S. Determination of synthesis, recycling and body mass of glucose in rats and rabbits in vivo 3H- and 14C-labelled glucose. Biochem J 1974;142:171-183
17. Steele R, Bishop JS, Dunn A, Altszuler N, Rathbeb I, Debodo RC. Inhibition by insulin of hepatic glucose production in the normal dog. Am J Physiol 1965;208:301-306
18. Katz J, Wood HG. The use of glucose-C14 for the evaluation of the pathways of glucose metabolism. J Biol Chem 1960;235:2165-2177
19. Katz J, Wood HG. The use of C14O2 yields from glucose-1- and -6-C14 for the evaluation of the pathways of glucose metabolism. J Biol Chem 1963;238:517-523
20. Treadway JL, Mendys P, Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 2001;10:439-454 (Pubitemid 32186142)
21. Kasvinsky PJ, Fletterick RJ, Madsen NB. Regulation of the dephosphorylation of glycogen phosphorylase a and synthase b by glucose and caffeine in isolated hepatocytes. Can J Biochem 1981;59:387-395 (Pubitemid 12195412)
22. Brady MJ, Saltiel AR. The role of protein phosphatase-1 in insulin action. Recent Prog Horm Res 2001;56:157-173
23. Pautsch A, Stadler N, Wissdorf O, Langkopf E, Moreth W, Streicher R. Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase. J Biol Chem 2008;283:8913-8918
24. Kelsall IR, Munro S, Hallyburton I, Treadway JL, Cohen PT. The hepatic PP1 glycogen-targeting subunit interaction with phosphorylase a can be blocked by C-terminal tyrosine deletion or an indole drug. FEBS Lett 2007;581:4749-4753 (Pubitemid 47418802)
25. Zibrova D, Grempler R, Streicher R, Kauschke SG. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Biochem J 2008;412:359-366 (Pubitemid 351758242)
26. Armstrong CG, Doherty MJ, Cohen PT. Identification of the separate domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 that interact with phosphorylase a, glycogen and protein phosphatase 1. Biochem J 1998;336:699-704 (Pubitemid 29008030)
27. Aiston S, Hampson LJ, Arden C, Iynedjian PB, Agius L. The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes. Diabetologia 2006;49:174-182 (Pubitemid 43151629)
28. Nawano M, Oku A, Ueta K, et al. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 2000;278:E535-E543 (Pubitemid 30149399)
29. Ercan-Fang N, Gannon MC, Rath VL, Treadway JL, Taylor MR, Nuttall FQ. Integrated effects of multiple modulators on human liver glycogen phosphorylase a. Am J Physiol Endocrinol Metab 2002;283:E29-E37 (Pubitemid 34686664)
30. McCormack JG, Westergaard N, Kristiansen M, Brand CL, Lau J. Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Curr Pharm Des 2001;7:1451-1474 (Pubitemid 32798820)
31. Wals PA, Katz J. A concentration gradient of glucose from liver to plasma. Metabolism 1993;42:1492-1496 (Pubitemid 23335885)
32. Niewoehner CB, Nuttall FQ. Relationship of hepatic glucose uptake to intrahepatic glucose concentration in fasted rats after glucose load. Diabetes 1988;37:1559-1566